The U.S. Homeland Security Dept. yesterday warned of two more cybersecurity vulnerabilities with the Alaris infusion pump made by Becton, Dickinson (NYSE:BDX). The DHS Industrial Control Systems Cyber Emergency Response Team, acting on weaknesses unearthed by researchers at CyberMDX, said the vulnerabilities could allow a malicious attacker to completely disable BD’s Alaris Gateway Workstation and install malware […]
Becton Dickinson & Co. (NYSE:BDX) subsidiary CareFusion has agreed to pay $3.3 million to settle civil fraud claims alleging that it sold products without FDA approval, according to a release from the U.S. Attorney’s Office for the Southern District of New York. San Diego-based CareFusion faced claims that it bought and sold medical devices not approved or […]
Retractable Technologies (NYSE:RVP) said this week it inked a settlement deal with Becton Dickinson (NYSE:BDX) to resolve a long-running suit claiming BD engaged in false advertising, according to an SEC filing. Little Elm, Texas-based Retractable Tech said the newly settled case was filed in 2007, when Retractable Tech filed a suit against BD claiming violations of antitrust […]
Becton Dickinson & Co. (NYSE:BDX) missed the consensus sales forecast for its fiscal second quarter and cut its outlook for the rest of the year, sending its share price down today on Wall Street. Franklin Lakes, N.J.-based BD pared its losses to -18 million, or -7¢ per share, on a -0.36% sales decline to $4.20 billion […]
The recent shutdown of a Sterigenics medical device sterilization plant in Willowbrook, Ill. has affected medtech giants such as Becton Dickinson (NYSE:BDX), Boston Scientific (NYSE:BSX), Medtronic (NYSE:MDT), Smith & Nephew (NYSE:SNN) and Stryker (NYSE:SYK), according to an FDA list of devices processed at the sterilization plant. Medium-sized and smaller firms, including Teleflex (NYSE:TFX), Arthrex and ArthroCare also had devices processed there. The Willowbrook plant sterilized 594 types of devices, including sutures, clamps, […]
A federal appeals court this week upheld a ruling that Becton Dickinson (NYSE:BDX) owes nothing more in a long-running false advertising claims case brought by Retractable Technologies (NYSE:RVP). The dispute dates back to 2001, when Little Elm, Texas-based RTI sued BD for patent infringement; that case settled for $100 million in 2004. RTI sued again barely three years […]
Medical device makers, regulators and healthcare delivery organizations are increasingly working together to strengthen cybersecurity. But are they doing enough? Almost no one in the medtech industry disputes the vulnerability posed by cyberattacks. How to go about boosting security is another matter – one on which those stakeholders have recently stepped up their collaboration. One […]
Becton Dickinson & Co. (NYSE:BDX) said today that the FDA granted pre-market approval for its Venovo stent for treating iliofemoral venous occlusive disease. Franklin Lakes, N.J.-based BD touted Venovo as the first on the U.S. market approved to treat obstructed blood flow in the iliac and femoral veins. “The FDA pre-market approval of the Venovo venous […]
Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard is removing its women’s pelvic organ prolapse and stress urinary incontinence mesh devices from the European Market, according to a recently posted field corrective action from the company. The Murray Hill, N.J.-based company said that it is “initiating a cease in production and distribution of these devices and a […]
Becton Dickinson (NYSE:BDX) said today that it won FDA 510(k) clearance for its WavelinQ 4 French endovascular arteriovenous fistula creation system. The Franklin Lakes, N.J.-based company said that the newly cleared WavelinQ 4F endoAVF system features improved technology that allows for the creation of an AVF in either the ulnar artery and ulnar vein or the radial […]
Becton Dickinson (NYSE:BDX) today posted fiscal year 2019 first quarter earnings that topped expectations on Wall Street, while share prices dipped slightly. The Franklin Lakes, N.J.-based company posted profits of $562 million, or $2.05 per share, on sales of $4.16 billion for the three months ended December 31, seeing a swing back into black ink on […]
MassDevice Network
@MassDevice
LinkedIn
YouTube